Raymond James Financial Services Advisors’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $584K | Sell |
|
|||||
|
2024
Q2 | $731K | Buy |
|
|||||
|
2024
Q1 | $586K | Sell |
|
|||||
|
2023
Q4 | $690K | Buy |
|
|||||
|
2023
Q3 | $556K | Sell |
|
|||||
|
2023
Q2 | $580K | Sell |
|
|||||
|
2023
Q1 | $917K | Sell |
|
|||||
|
2022
Q4 | $1.01M | Sell |
|
|||||
|
2022
Q3 | $1.44M | Sell |
|
|||||
|
2022
Q2 | $2.01M | Buy |
|
|||||
|
2022
Q1 | $1.87M | Buy |
|
|||||
|
2021
Q4 | $1.49M | Buy |
|
|||||
|
2021
Q3 | $1.55M | Buy |
|
|||||
|
2021
Q2 | $1.79M | Buy |
|
|||||
|
2021
Q1 | $1.6M | Buy |
|
|||||
|
2020
Q4 | $1.04M | Buy |
|
|||||
|
2020
Q3 | $697K | Sell |
|
|||||
|
2020
Q2 | $975K | Buy |
|
|||||
|
2020
Q1 | $761K | Buy |
|
|||||
|
2019
Q4 | $806K | Sell |
|
|||||
|
2019
Q3 | $1.02M | Sell |
|
|||||
|
2019
Q2 | $1.29M | Buy |
|
|||||
|
2019
Q1 | $1.39M | Buy |
|
|||||
|
2018
Q4 | $526K | Sell |
|
|||||
|
2018
Q3 | $546K | Buy |
|
|||||
|
2018
Q2 | $436K | Sell |
|
|||||
|
2018
Q1 | $822K | Buy |
|
|||||
|
2017
Q4 | $881K | Sell |
|
|||||
|
2017
Q3 | $1.04M | Sell |
|
|||||
|
2017
Q2 | $1.09M | Buy |
|
|||||
|
2017
Q1 | $806K | Sell |
|
|||||
|
2016
Q4 | $976K | Sell |
|
|||||
|
2016
Q3 | $1.08M | Buy |
|
|||||
|
2016
Q2 | $671K | Buy |
|
|||||
|
2016
Q1 | $1.02M | Buy |
|
|||||
|
2015
Q4 | $1.48M | Sell |
|
|||||
|
2015
Q3 | $1.17M | Buy |
|